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Abstract
Background: There are striking differences in breast cancer incidence between
Asian and western women. Rates vary substantially within Asia also, with
Mongolia’s even lower than China’s. These profound differences have been
speculated to be due in part to diet, mediated by circulating hormone
concentrations.
Methods: Sex steroid hormone concentrations were measured in women living in
Ulaanbaatar, Mongolia and the United Kingdom (U.K.). Diet was obtained by
interview and national survey data. Mean hormone differences were compared by
country, and systematic variation by number of days since last menstrual period
was modeled and adjusted for age and parity; difference in overall area under the
curves was assessed.
Findings: The diet in Mongolia was higher in meat and dairy than in the U.K. Mean
testosterone concentrations were 18.5% lower (p,0.0001) while estradiol
concentrations were 19.1% higher (p50.02) in Mongolian than British women,
adjusted for age and parity. Progesterone was almost 50% higher in Mongolian
women (p50.04), particularly during the follicular phase and early luteal surge.
Hormone concentrations generally were similar in Mongolian women born in
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Ulaanbaatar compared with those born in rural areas, although there was a
decreasing progesterone trend by degree of westernization (rural Mongolia; urban
Mongolia; U.K.). Mean hormone differences were similar when restricted to parous
women, and with further adjustment for body mass index, height, and smoking
status.
Interpretation: These data augment accumulating evidence that circulating
estrogens are unlikely to explain reduced breast cancer rates in Asia compared
with the west, and suggest casting a wider net with respect to biomarkers. Lower
testosterone and higher progesterone in Mongolian women raise the possibility that
these hormones may be important to consider. In addition, the almost exclusive
dietary reliance of Mongolians on meat and dairy argues against beneficial effects
of a low-fat diet on circulating hormones explaining international breast cancer
differences.
Introduction
A woman’s birth country is one of the strongest established risk factors for breast
cancer, with historical pre- and postmenopausal incidence rates in western
countries substantially greater than in Asian countries [1] (e.g., estimated age-
standardized incidence rates for breast cancer in 2012 were 95 per 100,000 person-
years in the United Kingdom (U.K.) and 9.4 per 100,000 in Mongolia) [2],
differences for which there is as yet no definitive explanation. Migrant studies
indicate that this vast disparity in breast cancer incidence rates is largely a function
of environmental factors [3]. While much of the differences could be due to
recognized reproductive risk factors, accounting for these still leaves a substantial
discrepancy in rates [4]. Another widely-held hypothesis is that lower dietary fat
consumption in low-risk compared with high-risk countries explains the reduced
risk in the former [5], either directly, or by increasing cumulative circulating
estrogens and other sex hormones.
Overlooked in the search for a biologic explanation are the substantial
differences in breast cancer incidence rates, as well as life-styles, within Asia, which
might be leveraged to help identify the responsible risk factors. We chose to
conduct a study in Mongolia, where the reported breast cancer incidence rate is
one-third that of China’s [6]. We compared selected dietary habits and
concentrations of several circulating hormones implicated in breast carcinogenesis
between premenopausal women living in Mongolia and the U.K.
Methods
The study was approved by ethical review boards at Mongolia’s Ministry of
Health, the National University of Mongolia, the United States (U.S.) National
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Cancer Institute (National Institutes of Health), the Harvard School of Public
Health, and the London School of Hygiene and Tropical Medicine. All
participants provided written, informed consent.
Data collection
In Mongolia, study participants were the mothers of school children attending
two primary schools in Ulaanbaator, the capital of Mongolia; one on the outskirts
of Ulaanbaatar (to increase the proportion of women who had recently moved
from rural areas) and the other in central Ulaanbaatar. Data were collected in the
spring of 2009 from mothers who were 45 years of age or younger, and who were
not pregnant or breastfeeding. Of the 420 invited women, 100% agreed to
participate; 199 from the school in the city’s outskirts, and 221 from the school in
the city center. Women who were currently using oral contraceptives were
excluded, leaving for analysis 137 women born in Ulaanbaatar and 177 women
born outside of Ulaanbaatar (born in all but two of the country’s 21 other
provinces).
Participants were interviewed by trained study staff about demographics,
migration and medical history. Dietary intake was based on a short food
frequency questionnaire that was developed by one of the authors (GD) which
queried participants on their weekly intake of a list of traditional and
contemporary Mongolian foods. Weight and height were measured by trained
personnel using standardized techniques. Whole blood was collected, and allowed
to clot at room temperature. Samples were then centrifuged and sera were stored
at 270 C˚. Participants reported date of first day of last menstrual period and
study staff subsequently contacted women to ascertain the first day of the next
menstrual period.
A comparison group from a western country was also chosen. These were
premenopausal Caucasian women from the U.K. who had been recruited
nationally between November 2008 and September 2009 as controls for a case-
control study on the genetics of breast cancer (the British Breast Cancer Study)
[7, 8]. Each case was asked to nominate an unaffected friend (or a blood-unrelated
relative) as a control. These women completed a questionnaire that included self-
reported height and weight and had blood samples drawn and processed, with
plasma stored at 270 C˚ for hormonal assays. The first day of their last menstrual
period and of the next cycle were obtained in the same manner as for the
Mongolian women. For the present study, 150 controls were chosen randomly; of
these, 129 women were included who were #50 years of age and not pregnant,
breastfeeding or currently using oral contraceptives. To qualitatively compare
dietary patterns with Mongolia, components were estimated from national dietary
surveys conducted in the U.K. [9] and China [10].
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Hormone assays
Hormones were measured at the Reproductive Endocrine Research Laboratory at
the University of Southern California, Keck School of Medicine under the direct
supervision of one of us (FS). Concentrations of estrone, estradiol, testosterone
and androstenedione were measured in a single serum or plasma aliquot by
radioimmunoassay (RIA) following extraction with organic solvent and separa-
tion of the steroids by Celite column partition chromatography, as described
previously [11–14]. Since progesterone co-elutes in the same fraction as
androstenedione on the Celite column, it was processed separately in the same
manner as the other steroids. Blinded aliquots of pooled sera and plasma were
included with the study samples, constituting 10% of each assay batch. The
laboratory technicians also were blinded to country of sample origin. The
coefficients of variations (CV) for the blinded serum and plasma samples were
6.2% and 6.5% for androstenedione, 8.2% and 8.1% for testosterone, 6.3% and
8.4% for estradiol, 4.9% and 5.9% for estrone, and 15.0% and 15.6% for
progesterone, respectively. Two Mongolian women’s values for estrone and
estradiol were several SD beyond the next highest values and were excluded from
analyses.
As noted, sera were available for the Mongolian women, and plasma for the
U.K. comparison group. While plasma and sera hormone assays are accepted as
yielding similar values, we assessed this specifically in a methods study by
measuring the hormones in paired plasma and serum samples from 10 U.S.
women, ages 39 to 42 years, who were not study participants. The laboratory was
blinded to whether the sample was plasma or serum. The difference in means,
representing combined intraassay error and difference in assay results (sera vs.
plasma) was,1% for estradiol, 4.5% for progesterone, 4.3% for androstenedione,
2.7% for testosterone and 7.1% for estrone (Table S1), and Pearson’s correlations
between hormones measured in plasma and serum were, respectively, 0.998,
0.997, 0.997, 0.974 and 0.996. For the statistical analysis, values for each of the
hormones were adjusted by adding constants to the serum values for the slight
differences in means between plasma and sera as determined in the methods
study. Using values with and without this adjustment yielded similar results (data
not shown).
Statistical analysis
The distribution of demographic and lifestyle characteristics for the two
populations were compared using chi-square statistics. Tertiles for height and
weight were based on the distribution of both populations combined. The
menstrual cycle was truncated at 28 days because of small numbers of women with
longer cycles (n53 in Mongolia; n510 in U.K.); results from analyses without
truncation were similar (data not shown). Generalized additive models using
logarithm transformed hormone values were used to assess mean differences in
hormone concentrations between countries, and by migration status within
Mongolia. Systematic variation according to the number of days since the first day
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of the last menstrual period was modeled using quadratic regression splines with
evenly spaced knots; the number of segments was selected using the AIC criterion
for all women combined without any adjustment for covariate effects [15]. Two
spline models were fitted for each hormone, a main effects model with a common
set of coefficients for the splined effects of days since last menstrual period, and an
interaction model with separate spline coefficients for each population group. The
interaction model was used to describe the observed hormone patterns in each
group, and the main effects model was used to formally test for mean hormone
concentration differences between populations using an F-Test. Both the main
effects and interaction models were adjusted for age and parity. Further
adjustment for smoking status, height and, body mass index (BMI) was evaluated.
The area under the regression spline curve was calculated by summing the
estimated spline-smoothed values at days 1–28 and variances were computed
using the standard delta method. Statistical significance of the difference in the
overall area under the curves, and for the follicular and luteal phases, was
estimated from analyses including all days since last menstrual period and for days
1–14 and 15–28, respectively. Regression analyses were repeated excluding the
25% of U.K. women who were nulliparous (all Mongolian women were parous).
Least square means for the hormone concentrations by age and parity were
calculated using Proc GLM in SAS, v9.2.
Results
The Mongolian women were younger, and of smaller stature and lower weight
than the U.K. women (Table 1), although lower BMI in the Mongolians was not
statistically significant. All of the Mongolian women (by study design–mothers of
school children) and 75% of the U.K. women were parous. Among parous
women, about 22% of the U.K. women had one child and 78% had two or more
compared with 8.5% and 92% of the Mongolians. Current smoking was higher
among Mongolian than U.K. women, although the majority of women in both
populations were nonsmokers. Women who migrated to Ulaanbaatar from other
Mongolian provinces were slightly older and more likely to be nonsmokers
compared with women who were born in Ulaanbaatar.
While the focus of this study was primarily on hormonal profiles, dietary habits
ascertained by interview in Mongolia also were compared with those in the U.K.
based on previously published national dietary surveys [9] (Table 2). The
Mongolian diet consists almost exclusively of meat and dairy products at levels
greater than those in the U.K. Women born outside Ulaanbaatar in the
countryside were more likely to consume the traditional meat and dairy diet [16].
Vegetables and fruits were consumed more often by women born in Ulaanbaatar
compared with women born in the countryside, and the former also tended to
consume more processed foods and sugar-sweetened drinks. Use of dietary
supplements was similar between women born in and outside of Ulaanbaatar.
Also for comparison, a published national dietary survey provided data for the
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Chinese diet of men and women living in urban and rural settings, 18–45 years of
age [10]. Compared with the Mongolian diet, the Chinese diet among men and
women relies more prominently on vegetables (including soy) and fish. The mean
intake per day was approximately 359 g for vegetables (not including potatoes),
29 g for fruit, 92 g for meat, 12 g for milk and milk products and 30 g for fish.
With adjustment for age and parity (Fig. 1; Table S2), mean testosterone
concentrations were 18.5% lower in women living in Mongolia than women living
in the U.K. (p,0.0001), while mean estradiol (p50.02) and progesterone
(p50.04) concentrations were 19.1% and 48.8% higher, respectively.
Androstenedione (p50.34; 4.6%) did not differ between groups while higher
estrone concentrations in Mongolian women (p50.08; 9.3%) did not reach
statistical significance. The differences in progesterone, estradiol and estrone
concentrations were most pronounced in days 0–14. In fact, the higher mean
Table 1. Characteristics of Mongolian and U.K. women.
Born outside UB Born in UB
p (born outside
vs. in UB) U.K. p (U.K. vs. Mongolia combined)
N5177 N5137 N5129
Age (years)
,30 17 (9.7) 22 (16.1)) 7 (5.4))
30–34 58 (33.1) 56 (40.9) 12 (9.3)
35–39 53 (30.3) 35 (25.6) 40 (31.0)
40–44 45 (25.7) 24 (17.5) 53 (41.1)
45–49 2 (1.1) 0 (0.0) 0.006 17 (13.2) ,0.0001
Height (tertiles; cm)
138.6–156.0 89 (50.3) 53 (38.7) 5 (3.9)
156.1–162.9 58 (32.8) 60 (43.8) 22 (17.2)
163.0–183.0 30 (17.0) 24 (17.5) 0.15 101 (78.9) ,0.0001
Weight (tertiles; kg)
35.8–58.5 71 (40.1) 60 (43.8) 16 (12.5)
58.6–68.5 62 (35.0) 37 (27.0) 48 (37.5)
68.6–124.0 44 (24.9) 40 (29.2) 0.94 64 (50.0) ,0.0001
BMI (weight(kg)/height2)
,20 12 (6.8) 10 (7.3) 3 (2.4)
20–25 79 (44.6) 65 (47.6) 58 (45.7)
.25 86 (48.6) 62 (45.3) 0.57 66 (52.0) 0.17
Parity
0 0 (0.0) 0 (0.0) 32 (25.0)
1 15 (8.5) 21 (15.3) 21 (16.4)
2+ 162 (91.5) 116 (84.7) 0.06 75 (58.6) ,0.0001
Current smoking
No 162 (91.5) 110 (80.3) 126 (97.7)
Yes 15 (8.5) 27 (19.7) 0.004 3 (2.3) ,0.0001
UB5Ulaanbaatar.
doi:10.1371/journal.pone.0114455.t001
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progesterone concentration in the Mongolian women appeared to be driven also
by the earlier and more rapid rise of the luteal surge, with the ultimate peak values
being similar between the two groups.
In general, mean hormone concentrations were similar in Mongolian women
who were born in Ulaanbaatar compared with those born in the countryside
(Fig. 2), with the exception of a borderline trend in progesterone with higher
values in Mongolian women born in the rural provinces (the lowest progesterone
values were in women living in the U.K; p for trend50.07). Mean hormone
differences noted above were similar in analyses that were restricted to parous
women (S1 Fig.), or when further adjusted for BMI, height, and smoking status
(S2 Fig.).
Discussion
Mongolian women, who have one of the lowest estimated breast cancer incidence
rates in the world, have substantially higher premenopausal circulating levels of
estradiol and progesterone, and lower levels of testosterone than women in the
U.K., who have much higher breast cancer rates. These hormone differences
between Mongolian and U.K. women are contrary to what has been assumed and
add to the growing evidence that estrogen differences are unlikely to explain the
lower breast cancer rates in Asia compared with the west [4]. Instead, they raise
interest in the possible etiologic roles for testosterone and progesterone. Also,
while our comparisons of dietary habits relied on different methodologies,
qualitatively it appears that the Mongolian diet is quite different from other low
breast cancer risk Asian populations, being based largely on meat and dairy
consumption at levels exceeding that of U.K. women.
While the largest international differences in breast cancer risk relate to the
postmenopausal period, there are substantial differences between premenopausal
Table 2. Components of Mongolian and U.K. diets.
Mongolia U.K.
Premenopausal women Women age 19–64
Servings/d g/d* Servings/d* g/d
Vegetables (w/o potatoes) 3.58 305 2.18 185
Fruit 1.24 105 1.21 103
Meat 1.64 164 0.88 88
Fish 0.07 7 0.23 23
Milk 1.84 445 0.51 124
yogurt 0.70 170 0.13 32
cheese 0.60 23 0.37 14
Cream, sour cream, butter 1.11 33 0.60 18
*estimated based on the following: For meat and fish 1 serving5100 g, for vegetables and fruits 1 serving585 g, for milk and yogurt 1 serving5242 g, for
butter, cream, and sour cream 1 serving530 g and for cheese 1 serving530–45 g.
doi:10.1371/journal.pone.0114455.t002
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women as well [1]. Furthermore, much of the speculation about the cumulative
estrogen dose affects on breast cancer risk pertains to the period before
menopause, as cumulative estrogen exposure is largely driven by the premeno-
pausal period because of its higher baseline concentrations. Mongolia’s estimates
of breast cancer incidence from the International Agency for Research on Cancer
(IARC) are based on national data (index of quality 5D5). While some of the
lower breast cancer incidence in Mongolia could be due to completeness of the
registry compared with other countries, it is unlikely to explain the entire three-
fold difference with respect to China. In addition, Mongolia is experiencing
dramatic socio-economic changes; as a result, there may be strong cohort effects
in breast cancer incidence – i.e. current rates mainly reflect incidence at older ages.
The women in the present study were premenopausal and their future breast
Fig. 1. Hormone concentrations in premenopausal Mongolian and U.K. women, adjusted for age and parity. Dashed lines 5 Mongolia; solid lines
5U.K.
doi:10.1371/journal.pone.0114455.g001
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cancer rates are likely to be higher than the current ones. However; this
phenomenon is occurring in other countries in transition as well, such as China.
Future differences in breast cancer incidence may be smaller between these
countries but are likely to remain.
Other limitations of our study should be mentioned. Our interpretation of
hormone differences between countries assumes that the populations sampled are
representative of the women living in Mongolia and UK. The population of UK
women that we included was born in areas throughout the country. This was also
true for the Mongolian population; the women born outside of Ulaanbaatar were
from all of the country’s provinces except two. This was the best approximation of
representativeness that we could achieve. The data we present on hormonal
differences, and to the extent possible, dietary differences, are meant to raise
hypotheses regarding possible underlying factors that explain the differences in
Fig. 2. Hormone concentrations in premenopausal Mongolian, born in and outside Ulaanbaatar, and U.K. women, adjusted for age and parity.
Dashed lines 5 rural Mongolia; dotted lines 5 urban Mongolia; solid lines 5U.K.
doi:10.1371/journal.pone.0114455.g002
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breast cancer incidence between countries. Unfortunately, we did not have
exhaustive information on environmental factors in both populations. Factors
that possibly differ between countries could include other dietary factors than
those presented, breastfeeding practices, stress, immune factors, sanitation,
exposure to livestock, and use of tobacco products and alcohol. Also, because we
relied on BMI as a measure of adiposity it is possible that adjustment for BMI did
not account for differences in fat distribution or other aspects of body fatness.
Speculation on factors responsible for the major differences in breast cancer rates
between Asians and Western women have focused primarily on recognized
reproductive and anthropometric risk factors, dietary fat intake, and levels of
circulating estrogens, with the later acting independently, and/or as a possible
biologic mediator of the effects of the other risk factors. While there is evidence that
differences in recognized risk factors play a role in explaining the international
cancer incidence gaps, they do not explain all of the disparities, and data to support
the dietary and hormonal hypotheses are absent or conflicting. Specifically, analytic
studies to date in western populations have not established a causal link between
dietary fat intake and breast cancer risk [17]. In addition, descriptive studies in
Chinese and U.S. women have found lower circulating estrogen levels in the
Chinese, however of a magnitude insufficient to explain the differences in risk [4].
This, combined with the results of the current investigation, indicate the need for
new hypotheses to explain international differences in breast cancer risk.
Although the differences we observed in hormones in the current study are
unlikely to fully explain the large difference in breast cancer incidence rates
between low and high risk populations, they provide two possibilities for further
consideration – testosterone and progesterone. Increased levels of circulating
testosterone have been associated with elevated breast cancer risk in both pre- and
post-menopausal women [18, 19]. This has often been dismissed as simply
reflecting testosterone’s role as an estrogen precursor. It might be prudent to
reevaluate the possibility that it plays a more direct role itself. Progesterone has
also been a hormone of great interest, but for a variety of mainly practical reasons
it has only infrequently been assessed in epidemiologic studies. When it has, no
consistent association with breast cancer has emerged. A recent pooled analysis of
breast cancer in seven prospective studies found no association with luteal phase
concentrations of progesterone [20]. One of the practical problems in measuring
progesterone, as well as estrogen, is the measurement error involved in attempting
to obtain samples on the same menstrual day for hormones that vary widely over
the cycle. Rather than rely on this approach, we sampled women without regard to
cycle day and then modeled the entire cycle for the groups we compared. This
method has seldom been used by epidemiologists, but we believe it has great
advantages both in reducing measurement error, and in allowing evaluation of
hormone profiles over the entire cycle. Interestingly, when the pooled analysis
above assessed studies that had measured hormones at different times in the
menstrual cycle, they did note significantly higher levels of progesterone in
controls than cases in the ‘‘early luteal phase.’’ This makes intriguing our
observation of progressively higher levels early in the progesterone surge moving
The Role of Hormones in International Breast Cancer Differences
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from rural Mongolians to urban Mongolians to British women, especially in light
of the lower breast cancer rates among the rural compared with urban Mongolians
that have been observed [6]. Whether the patterns of progesterone levels in our
study reflect greater production by Mongolian women immediately following
ovulation, or a shift in ovulation to earlier in the cycle is not clear, and merits
further evaluation.
Panel: Research in Context
Background
There are striking differences in breast cancer incidence rates between Asian and
western women. It is less recognized that incidence varies substantially within
Asia, a large geographical area comprised of varying lifestyles and diets, with
Mongolian women experiencing one of the lowest rates in the world; one-tenth
that of the U.K. The explanation for these profound differences is unknown but
has been speculated to be due in part to diet, mediated by circulating hormone
concentrations associated with breast cancer risk.
Interpretation
Our study adds to accumulating evidence that estrogen concentrations do not
explain reduced breast cancer rates in Asian countries compared with those in the
west, and suggest the utility of casting a wider net with respect to biomarkers.
Lower testosterone concentrations and higher progesterone concentrations during
the early luteal surge in Mongolian women suggest the possibility that these
hormones may be important in the breast cancer protection afforded Asian
women. In addition, the heavy dietary reliance of Mongolians on meat and dairy
argues against beneficial effects of a low-fat diet on circulating hormones
explaining international differences in breast cancer risk.
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S1 Fig. Hormone concentrations in premenopausal, parous women from
Mongolia and the U.K., adjusted for age. Dashed lines 5 Mongolia; solid lines
5U.K.
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